Yes. Look, the evolution of the unregulated drug market is predictably unpredictable. I think we need to trace this back to the late 19th century. We had opium, then laudanum, then heroin, then fentanyl, then carfentanil and then nitazene-class opioids. Every step of the way, as there's been more pressure placed on drug markets, unregulated drug markets have adapted and evolved.
It's like any other market. I think of the smart phone market. There's pressure for evolution in markets. That's why we started with giant phones that couldn't do anything, and now we have smaller and smaller phones with incredible computing power.
Unfortunately, what we have right now is pressure from law enforcement and seizures that are incentivizing innovation on the part of drug trafficking organizations. If we want to address overdose in a meaningful, structural, long-term and sustainable way, I think we need to look at the source of the innovation that's happening in the unregulated drug market and think about structural ways that we can apply some stasis to the market.
I'll leave it there.